Islamic Finance Principles Assessment
Riba — Does Medibloc involve interest?
MediBloc's core protocol does not generate interest-based revenue; its income model runs through gas fees, validator commission, and emerging voucher utility rather than lending spreads. However, staking rewards partly derive from block-reward inflation rather than purely from fee revenue, which introduces a nuance Muslim investors should weigh. On balance, MED's structure avoids explicit riba mechanisms, though the inflationary component of rewards warrants scrutiny rather than blanket approval.
Assessment: Moderate Riba
Score: 64/100
Our methodology examines 10 criteria to evaluate how well Medibloc avoids interest-based mechanisms.
No source discloses a formalized protocol revenue model generating interest income for MediBloc or its foundation treasury. The project's monetization instead centers on the Dr.palette EMR platform, hospital partnerships, and MED-based voucher schemes with partners like Open Asset Inc., none of which involve interest-bearing instruments. Gas fees paid on the Panacea chain are distributed to validators and delegators as compensation for network validation, not retained as interest-bearing treasury holdings. Third-party exchanges and DeFi venues may offer MED lending or yield products, but these sit outside MediBloc's own protocol design and do not reflect the coin's intended function.
Panacea's DPoS staking rewards are variable, not fixed: they combine block-reward inflation with transaction gas fees, apportioned by votes received and reduced by validator-set commission. This distinguishes the mechanism from a guaranteed interest payment, since returns fluctuate with participation rates, validator performance, and network activity — the roughly 49% annualized figure cited by Coinbase reflects a low ~21% staking ratio diluting rewards, not a promised yield. Still, because a portion of rewards originates from newly minted tokens rather than solely from fee revenue tied to genuine economic activity, the permissibility of this inflationary component as a service-fee-like arrangement remains an open question not settled in available sources.
Gharar — How much uncertainty does Medibloc involve?
MediBloc carries moderate uncertainty: its team and technology are well-documented, but its audit trail and reward-classification questions leave gaps. Transparency around founders and open-source code reduces gharar, while the absence of a confirmed protocol audit increases it. Overall, the uncertainty here is manageable but not negligible, and investors should treat the unaudited status as a real, unresolved risk factor.
Assessment: Moderate Gharar (Material Uncertainty)
Score: 62/100
Our methodology examines 15 criteria including team transparency, audit quality, and governance.
MediBloc's founders are named and credentialed: Dr. Allen Wookyun Kho (KAIST, Columbia, former Samsung engineer, now a dentist) and Dr. Eunsol Lee (Hanyang University-trained radiologist, biomedical informatics specialist). The whitepaper and core repositories are open-source on GitHub, allowing independent verification of protocol mechanics. A post-ICO rating report noted some team LinkedIn profiles carry few endorsements, though this is partly attributed to lower LinkedIn usage patterns in South Korea rather than concealment. No sources indicate fraud, hacks, or regulatory action against MediBloc itself, distinguishing it from opportunistic anonymous-team projects.
No security audit of the MediBloc or Panacea protocol, or its smart contracts, could be identified in available research; audit reports sometimes associated with MediBloc in searches (from Halborn) actually pertain to unrelated projects, Substance Exchange and Reef Finance. This absence of a confirmed, named audit for MediBloc's own codebase is a legitimate gharar concern and should be stated plainly rather than assumed away. Official Panacea documentation covers validator mechanics, unbonding periods (three weeks, with slashing risk during that window), and CLI usage, which offers reasonable operational transparency, but does not substitute for independent code-security verification.
Maysir — Does Medibloc involve gambling or speculation?
MediBloc is not designed as a speculative or gambling instrument; its stated purpose is patient-owned health-record infrastructure with real hospital integrations. Some speculative trading naturally occurs on secondary markets, as with virtually any listed token, but this reflects market behavior rather than protocol design. The project's genuine utility base supports a favorable maysir assessment, distinct from tokens whose only function is price speculation.
Assessment: Moderate Maysir (High Risk)
Score: 61.8/100
Our methodology examines 11 criteria to determine whether Medibloc is a gambling instrument or a genuine economic tool.
Panacea's core function — hashing and immutably recording patient-controlled medical data while giving hospitals validator roles — represents genuine productive utility rather than a wagering mechanism. MediBloc has secured Korean regulatory sandbox approval for its Dr.palette EMR product and continues forming hospital partnerships through 2024-2025, indicating real institutional adoption beyond token trading. Its emerging voucher partnerships extend MED into tangible healthcare and retail redemption use cases. This orientation toward solving a real data-ownership problem in healthcare distinguishes MED from instruments whose value proposition is purely price movement or chance-based payout.
Against this genuine utility, MED does trade with meaningful volume ($13M/24h) on major exchanges, and its comparatively small staking market cap ($14M) relative to trading volume suggests speculative turnover exceeds locked, productive participation. This is typical of many utility tokens and does not itself indicate gambling-like design. Since MediBloc's protocol does not incentivize wagering, lotteries, or leveraged betting internally, and third-party speculative trading is a feature of secondary markets generally rather than something the protocol promotes, the coin's own design leans toward permissible productive use rather than maysir.
The Full 27-Point Screening
1. Legitimacy (4 criteria)
| Criterion | Score | Analysis |
|---|
| Team Transparency | 80/100 | Founders are publicly named with verifiable credentials and professional history. |
| Fraud & Scam Risk | 75/100 | No fraud, hack or rug-pull indicators are reported, and the project has operated continuously with partnerships since 2017. |
| Use Case Legitimacy | 85/100 | Clear healthcare-data use case is documented through hospital integrations and regulatory approvals. |
| Ethical Practices | 90/100 | The protocol's own design serves healthcare data management, a sector with no inherent Shariah concern. |
Summary: MediBloc is led by named, credentialed medical and engineering co-founders with a multi-year track record of healthcare partnerships and no reported fraud or rug-pull indicators.
2. Project Operations (9 criteria)
| Criterion | Score | Analysis |
|---|
| Core Protocol Business | 90/100 | Core protocol is a healthcare information blockchain, not a prohibited sector. |
| Transaction Fees | 65/100 | Gas fees are distributed to validators and delegators as compensation for work rather than extracted as a riba-like charge, though they are not burned. |
| Treasury Assets | 45/100 (low evidence) | The composition of the foundation reserve is not disclosed, so whether it holds interest-bearing instruments cannot be established. |
| Revenue Model | 55/100 | Revenue appears tied to voucher and utility partnerships rather than interest, but no explicit revenue model is disclosed. |
| Transparency | 85/100 | Whitepaper and code repositories are publicly available on GitHub. |
| Governance | 55/100 | Governance runs through validator elections including medical-institution validators, though early centralization existed before the coin swap. |
| Launch Fairness | 45/100 | The ICO-based launch allocated a substantial combined share to foundation, team and partners alongside the public sale, which is not a pure fair launch. |
| Token Distribution | 50/100 | Distribution is disclosed and includes vesting, but insider allocations are sizeable relative to the community share. |
| Speculation/Utility Ratio | 65/100 | The project shows genuine utility development through EMR services, vouchers and hospital partnerships rather than pure hype, though it also trades speculatively. |
Summary: The Panacea protocol is an open-source DPoS healthcare-data blockchain with disclosed but insider-heavy initial token distribution and validator-based governance.
3. Financial Health (4 criteria)
| Criterion | Score | Analysis |
|---|
| Protocol Revenue | 75/100 | No interest-based revenue source is described; income appears tied to ecosystem utility rather than lending. |
| Financial Status | 50/100 | Market and volume data exist, but overall financial stability and treasury health are not detailed in the sources. |
| Interest Assessment | 85/100 | The base Panacea protocol itself does not offer lending or borrowing; third-party platforms that do so are explicitly separate. |
| Audit Quality | 20/100 (low evidence) | No security audit of the MediBloc/Panacea protocol or its contracts could be located; retrieved audit reports concern unrelated projects. |
Summary: MED shows genuine market activity and ecosystem partnerships but lacks a clearly disclosed revenue model, treasury composition, and any identifiable third-party audit of its own codebase.
4. Token Economics (5 criteria)
| Criterion | Score | Analysis |
|---|
| Token Purpose | 80/100 | MED serves clear utility functions such as gas payment, staking collateral and voucher payments rather than being a meme token. |
| Governance Rights | 65/100 | Holders can vote for validators, giving a governance function tied to token holdings. |
| Rewards Distribution | 70/100 | Rewards vary with votes received, validator commission and inflation rather than being fixed. |
| Speculation Controls | 30/100 (low evidence) | No anti-speculation mechanisms such as trading limits or burn schedules are described in the sources. |
| Asset Backing | 55/100 | The token is not backed by a hard asset; its value is tied to network utility and adoption rather than collateral. |
Summary: MED is a utility-oriented token used for fees, staking collateral and emerging real-world vouchers, with variable, inflation- and fee-driven rewards rather than fixed returns.
5. Staking Mechanism (5 criteria)
| Criterion | Score | Analysis |
|---|
| Mechanism Type | 75/100 | Staking is non-custodial delegation with a documented three-week unbonding period. |
| Islamic Contract Classification | 45/100 | Rewards blend inflationary minting with fee-sharing under a delegated-validation structure, and no source classifies this under a specific Islamic contract, leaving the underlying treatment unresolved. |
| Rewards Structure | 55/100 | Reward mechanics are explicitly variable, based on votes, commission and gas fees rather than a guaranteed fixed rate. |
| Documentation | 75/100 | Official Panacea documentation explains staking mechanics, unbonding and slashing risk. |
| Shariah Alignment | 50/100 | Slashing risk and inflation-funded rewards introduce uncertainty and an unresolved classification question that keeps overall alignment only moderate. |
Summary: MediBloc runs a native non-custodial DPoS staking system with slashing and a three-week unbonding period, though the Islamic contract classification of its inflation-based rewards remains unaddressed in available sources.
Overall Assessment: MediBloc presents as a legitimate, utility-driven healthcare blockchain project whose main Shariah-relevant gaps are the absence of a confirmed audit and an unresolved classification of its inflationary staking rewards.
Written by ThanvirFounder, Ex Director S&P Global Energy
Reviewed by Imam Omar SiddiqiShariah Scholar